Recent developments in cancer therapy and diagnosis
- 4 March 2020
- journal article
- review article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 50 (4) , 349-361
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveAdvanced Drug Delivery Reviews, 2017
- Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesCancer Chemotherapy and Pharmacology, 2015
- Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphomaVirchows Archiv, 2014
- Dynamic disordering of liposomal cocktails and the spatio-temporal favorable release of cargoes to circumvent drug resistanceBiomaterials, 2014
- Assessing the barriers to image‐guided drug deliveryWIREs Nanomedicine and Nanobiotechnology, 2013
- Effector CD4 and CD8 T Cells and Their Role in the Tumor MicroenvironmentCancer Microenvironment, 2012
- T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2International Journal of Cancer, 2010
- New Generation of Multifunctional Nanoparticles for Cancer Imaging and TherapyAdvanced Functional Materials, 2009
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- pH‐Responsive PEG‐Poly(β‐amino ester) Block Copolymer Micelles with a Sharp TransitionMacromolecular Rapid Communications, 2006